The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia.

BMC Med Genomics · 2024 · PMC11137891 · PMID 38811988

Europe PMC DOI

hedged sentence

0.0006

closest p · 0.0× alpha

0.0006

boldest claim

The sentences

highly significantp = 0.00059actually significant

The differences were highly significant for AC005258 ( p = 0.00059), ZBTB7A ( p = 0.00181), SLC16A3 ( p = 0.00185), MBP ( p = 0.00478), SLC66A2 ( p = 0.00519), CTBP1 ( p = 0.00572), CDC42 ( p = 0.00572), ZNF516 ( p = 0.00572), SIN3A ( p = 0.0109), RUNX1 ( p = 0.0109), C15orf39 ( p = 0.0109), OAZ1 ( p = 0.01262), ETV6 ( p = 0.0166), DMD ( p = 0.02509), NFATC1 ( p = 0.03528), and AL591378 ( p = 0.03765).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.